Bookrunners Jefferies and Cowen plan to sell 6.5 million common shares
By Devika Patel
Knoxville, Tenn., June 6 – Radius Health, Inc. said it priced its $52 million initial public offering of stock with a $7.8 million greenshoe. The deal was announced April 25.
The company will sell 6.5 million common shares at $8.00 apiece.
Jefferies LLC and Cowen and Co., LLC are the joint bookrunning managers.
Existing stockholders, including BB Biotech AG, Brookside Capital Partners Fund, LP and F2 Ventures, have indicated an interest in investing up to $19 million.
Settlement is expected June 11.
Proceeds will be used to fund the clinical development of the company’s most advanced product candidates and for other corporate purposes.
The biopharmaceutical company is based in Cambridge, Mass. It has applied to list its common stock on the Nasdaq Global Market under the symbol “RDUS.”
| Issuer: | Radius Health, Inc.
|
| Issue: | Common stock
|
| Amount: | $52 million
|
| Greenshoe: | $7.8 million
|
| Shares: | 6.5 million
|
| Price: | $8.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies LLC and Cowen and Co., LLC
|
| Co-lead manager: | Canaccord Genuity Inc.
|
| Co-manager: | Cantor Fitzgerald & Co.
|
| Investors: | BB Biotech AG, Brookside Capital Partners Fund, LP and F2 Ventures
|
| Announcement date: | April 25
|
| Pricing date: | June 6
|
| Settlement date: | June 11
|
| Stock exchange: | Nasdaq: RDUS
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
